GeoPharma Inc. announced that they will report Q2, 2010 results before the start of trading on November 24, 2009.

GeoPharma Inc., Q2 2010 Earnings Call, Nov-24-2009

GeoPharma Inc. received a staff deficiency letter, indicating that the company does not comply with the minimum bid price requirement for continued listing on the NASDAQ exchange. NASDAQ listing rules require listed securities to maintain a minimum bid price of $1 per share. The firm said in a release that based upon the closing bid price for the last 30 consecutive business days, GeoPharma no longer meets this requirement. The rules also provide a grace period of 180 calendar days in which to regain compliance. If at any time during this grace period the bid price of the company's security closes at or above $1 per share for a minimum of 10 consecutive business days, NASDAQ will provide the company with a written confirmation of compliance. If GeoPharma does not regain compliance with the rule prior to the expiration of the grace period, the company may be eligible for an additional grace period if it meets the initial listing standards, with the exception of bid price, for the NASDAQ Capital Market. If the company meets the initial listing criteria, it will be granted an additional 180-calendar day grace period for compliance. GeoPharma said in the release that it understands the NASDAQ requirements and believes it will be able to re-enter compliance of the ruling within the allotted grace period.